LSV Asset Management Grows Position in Maximus, Inc. $MMS

LSV Asset Management raised its stake in shares of Maximus, Inc. (NYSE:MMS) by 112.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,700 shares of the health services provider’s stock after purchasing an additional 63,800 shares during the period. LSV Asset Management owned 0.21% of Maximus worth $11,028,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Johnson Investment Counsel Inc. increased its position in Maximus by 1.3% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 31,285 shares of the health services provider’s stock worth $2,859,000 after purchasing an additional 397 shares in the last quarter. Profund Advisors LLC purchased a new stake in Maximus during the third quarter worth approximately $211,000. Oppenheimer Asset Management Inc. increased its position in shares of Maximus by 67.6% in the third quarter. Oppenheimer Asset Management Inc. now owns 11,541 shares of the health services provider’s stock worth $1,055,000 after acquiring an additional 4,657 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in shares of Maximus in the 3rd quarter valued at $484,000. Finally, Savant Capital LLC raised its stake in shares of Maximus by 31.3% in the 3rd quarter. Savant Capital LLC now owns 13,201 shares of the health services provider’s stock valued at $1,206,000 after acquiring an additional 3,146 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

Maximus stock opened at $74.75 on Friday. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $100.00. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. The stock has a market cap of $4.08 billion, a P/E ratio of 11.38 and a beta of 0.57. The stock has a 50 day moving average of $89.09 and a 200-day moving average of $86.58.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the previous year, the firm earned $1.61 earnings per share. The business’s revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is currently 18.26%.

Insider Buying and Selling

In other Maximus news, CFO David Mutryn purchased 1,000 shares of Maximus stock in a transaction on Monday, February 9th. The stock was bought at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the transaction, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. The trade was a 2.56% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Bruce Caswell bought 3,175 shares of the stock in a transaction on Tuesday, February 10th. The shares were bought at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the purchase, the chief executive officer owned 328,013 shares in the company, valued at $25,732,619.85. This trade represents a 0.98% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 4,231 shares of company stock valued at $329,521. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on MMS shares. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Strong Buy”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.